pharmacists role

How health execs can partner with pharmacists to address opioidsDirector of medication safety and quality for the American Society of Health-System Pharmacists shares how providers can better work with pharmacists to address the opioid epidemic.
ISMP issues insulin pen warning after patient deathMore education is needed for diabetic patients after a patient died from incorrectly using an insulin pen, according to a new warning from the Institute for Safe Medication Practices.
Opinion: Four reasons Texas Health Aetna joint venture is workingAs the industry moves to a value-based care model, here’s how one North Texas partnership is reinventing healthcare.
Five ways health executives can impact the opioid crisisConsider these five opportunities to help curb one of the biggest public health issues of the year.
Four ways PBMs must change to thrive in the future
Four ways PBMs must change to thrive in the futureThe days of the traditional, channel-focused and largely enshrouded PBM business model have come and gone. Here’s what’s next.
Adding biosimilars to formularies: The pharmacist's rolePharmacists on P&T committees are going to face issues that range from biosimilar naming systems to challenges in dispensing and costs.
How pharmacists should be fighting the heroin epidemicOnce we as individuals in the healthcare profession finally begin to accept addiction as a disease and not a moral failing, the affected individuals will have a better chance at recovery and we will gain a better understanding of this epidemic.
Two states to allow pharmacists to prescribe birth controlPharmacists in California and Oregon will soon be able to prescribe birth control.
Clinical detachment vs. personal touch in pharmacyPharmacists must walk a careful line in the practice of ambulatory care pharmacy. Here are some things to think about.
Rx errors in HIV patients can be reduced by pharmacistsA pharmacist who is proficient at monitoring and ensuring appropriate therapy, as well as providing necessary medication counseling, will greatly enhance compliance and reduce potential adverse drug reactions and interactions in HIV-positive hospital patients, according to FormularyWatch advisor James M. Wooten, PharmD, associate professor, department of medicine, section of clinical pharmacology, University of Missouri-Kansas City.